therapeuticЮжно-Российский журнал терапевтической практикиSouth Russian Journal of Therapeutic Practice2712-81563033-8344РостГМУ10.21886/2712-8156-2022-3-1-15-19therapeutic-197Research ArticleОБЗОРЫREVIEWSПоражение сердца у больных с ревматоидным артритомHeart damage in patients with rheumatoid arthritishttps://orcid.org/0000-0002-3463-7734РебровА. П.RebrovA. P.

Ребров Андрей Петрович – доктор медицинских наук, профессор, заведующий кафедрой госпитальной терапии лечебного факультета.

Саратов.

Andrey P. Rebrov - Dr. Sci. (Med.), professor, head of the chair of hospital therapy of general medicine Department, V.I. Razumovskyy Saratov State Medical University.

Saratov.

aprebrov@yandex.ruСаратовский государственный медицинский университет им. В.И. Разумовского Минздрава РоссииРоссияV.I. Razumovskyy Saratov State Medical UniversityRussian Federation202216032022311519Copyright © Ребров А.П., 20222022Ребров А.П.Rebrov A.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.therapeutic-j.ru/jour/article/view/197

В статье представлены данные о поражении сердца у пациентов с ревматоидным артритом (РА), особенностях развития ишемической и неишемической болезни сердца с существенным повышением риска неблагоприятных сердечно-сосудистых событий. Для пациентов с РА характерно повышение риска развития инфаркта миокарда, сердечной недостаточности, нарушений ритма, внезапной сердечной смерти и общей сердечно-сосудистой смерти. Подчёркивается возможность достаточно быстрого развития дисфункции миокарда у пациентов с РА с момента манифестации заболевания, развития и прогрессирования атеросклероза коронарных артерий, а при развитии у больных РА поражения коронарных артерий установлена худшая выживаемость после перенесенного инфаркта миокарда.

Имеющиеся факты позволяют говорить о ревматоидном артрите как о заболевании, вносящем существенный вклад в сердечно-сосудистую заболеваемость и смертность.

The article presents data on heart damage in patients with rheumatoid arthritis (RA), features of the development of ischemic and non-ischemic heart disease with a significant increase in the risk of adverse cardiovascular events. Patients with RA are characterized by an increased risk of developing myocardial infarction, heart failure, rhythm disturbances, sudden cardiac death, and general cardiovascular death. The possibility of a fairly rapid development of myocardial dysfunction in patients with RA from the moment of manifestation of the disease, the development and progression of atherosclerosis of the coronary arteries is emphasized, and with the development of coronary artery disease in RA patients, the worst survival rate after a heart attack was established. The available evidence suggests that rheumatoid arthritis is a disease that makes a significant contribution to cardiovascular morbidity and mortality.

ревматоидный артритсердцемиокардсердечно-сосудистая заболеваемость и смертностьrheumatoid arthritisheartmyocardiumcardiovascular morbidity and mortalityReferencesAvina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71(9):1524-9. DOI: 10.1136/annrheumdis-2011-200726.Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71(9):1524-9. DOI: 10.1136/annrheumdis-2011-200726.Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690-7. DOI: 10.1002/art.24092.Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690-7. DOI: 10.1002/art.24092.Lacaille D, Avina-Zubieta JA, Sayre EC, Abrahamowicz M. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis. 2017;76(6):1057-1063. DOI: 10.1136/annrheumdis-2016-209562.Lacaille D, Avina-Zubieta JA, Sayre EC, Abrahamowicz M. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis. 2017;76(6):1057-1063. DOI: 10.1136/annrheumdis-2016-209562.Provan SA, Lillegraven S, Sexton J, Angel K, Austad C, Haavardsholm EA, et al. Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study. Rheumatology (Oxford). 2020;59(3):505-512. DOI: 10.1093/rheumatology/kez371.Provan SA, Lillegraven S, Sexton J, Angel K, Austad C, Haavardsholm EA, et al. Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study. Rheumatology (Oxford). 2020;59(3):505-512. DOI: 10.1093/rheumatology/kez371.Bernardes M, Vieira TS, Martins MJ, Lucas R, Costa L, Pereira JG, et al. Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers. Biomed Res Int. 2017;2017:6509754. DOI: 10.1155/2017/6509754.Bernardes M, Vieira TS, Martins MJ, Lucas R, Costa L, Pereira JG, et al. Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers. Biomed Res Int. 2017;2017:6509754. DOI: 10.1155/2017/6509754.Mal K, Kumar R, Mansoor F, Kaur N, Kumar A, Memon S, et al. Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis. Cureus. 2020;12(12):e12246. DOI: 10.7759/cureus.12246.Mal K, Kumar R, Mansoor F, Kaur N, Kumar A, Memon S, et al. Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis. Cureus. 2020;12(12):e12246. DOI: 10.7759/cureus.12246.DeMizio DJ, Geraldino-Pardilla LB. Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis. Rheumatol Ther. 2020;7(1):19-33. DOI: 10.1007/s40744-019-00189-0.DeMizio DJ, Geraldino-Pardilla LB. Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis. Rheumatol Ther. 2020;7(1):19-33. DOI: 10.1007/s40744-019-00189-0.Btyszczuk P, Szekanecz Z. Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis. RMD Open. 2020;6(1):e001032. DOI: 10.1136/rmdopen-2019-001032.Btyszczuk P, Szekanecz Z. Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis. RMD Open. 2020;6(1):e001032. DOI: 10.1136/rmdopen-2019-001032.Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, et al. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. JACC Cardiovasc Imaging. 2015;8(5):526-536. DOI: 10.1016/j.jcmg.2014.12.025.Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, et al. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. JACC Cardiovasc Imaging. 2015;8(5):526-536. DOI: 10.1016/j.jcmg.2014.12.025.Amigues I, Tugcu A, Russo C, Giles JT, Morgenstein R, Zartoshti A, et al. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis. Arthritis Rheumatol. 2019;71(4):496-506. DOI: 10.1002/art.40771.Amigues I, Tugcu A, Russo C, Giles JT, Morgenstein R, Zartoshti A, et al. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis. Arthritis Rheumatol. 2019;71(4):496-506. DOI: 10.1002/art.40771.Rudominer RL, Roman MJ, Devereux RB, Paget SA, Schwartz JE, Lockshin MD, et al. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum. 2009;60(1):22-9. DOI: 10.1002/art.24148.Rudominer RL, Roman MJ, Devereux RB, Paget SA, Schwartz JE, Lockshin MD, et al. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum. 2009;60(1):22-9. DOI: 10.1002/art.24148.Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Gatti D, Adami S, et al. Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study. Herz. 2015;40(7):989-96. DOI: 10.1007/s00059-015-4320-5.Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Gatti D, Adami S, et al. Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study. Herz. 2015;40(7):989-96. DOI: 10.1007/s00059-015-4320-5.Pascale V, Finelli R, Giannotti R, Coscioni E, Izzo R, Rozza F, et al. Cardiac eccentric remodeling in patients with rheumatoid arthritis. Sci Rep. 2018;8(1):5867. DOI: 10.1038/s41598-018-24323-0.Pascale V, Finelli R, Giannotti R, Coscioni E, Izzo R, Rozza F, et al. Cardiac eccentric remodeling in patients with rheumatoid arthritis. Sci Rep. 2018;8(1):5867. DOI: 10.1038/s41598-018-24323-0.Aslam F, Bandeali SJ, Khan NA, Alam M. Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken). 2013;65(4):534-43. DOI: 10.1002/acr.21861.Aslam F, Bandeali SJ, Khan NA, Alam M. Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken). 2013;65(4):534-43. DOI: 10.1002/acr.21861.Amigues I, Russo C, Giles JT, Tugcu A, Weinberg R, Bokhari S, et al. Myocardial Microvascular Dysfunction in Rheumatoid ArthritisQuantitation by 13N-Ammonia Positron Emission Tomography/Computed Tomography. Circ Cardiovasc Imaging. 2019;12(1):e007495. DOI: 10.1161/CIRCIMAGING.117.007495.Amigues I, Russo C, Giles JT, Tugcu A, Weinberg R, Bokhari S, et al. Myocardial Microvascular Dysfunction in Rheumatoid ArthritisQuantitation by 13N-Ammonia Positron Emission Tomography/Computed Tomography. Circ Cardiovasc Imaging. 2019;12(1):e007495. DOI: 10.1161/CIRCIMAGING.117.007495.Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17-28. DOI: 10.1136/annrheumdis-2016-209775.Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17-28. DOI: 10.1136/annrheumdis-2016-209775.Wang H, Li X, Gong G. Cardiovascular outcomes in patients with co-existing coronary artery disease and rheumatoid arthritis: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99(14):e19658. DOI: 10.1097/MD.0000000000019658.Wang H, Li X, Gong G. Cardiovascular outcomes in patients with co-existing coronary artery disease and rheumatoid arthritis: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99(14):e19658. DOI: 10.1097/MD.0000000000019658.Lai CH, Hsieh CY, Barnado A, Huang LC, Chen SC, Tsai LM, et al. Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Rheumatology (Oxford). 2020;59(6):1355-1363. DOI: 10.1093/rheumatology/kez456.Lai CH, Hsieh CY, Barnado A, Huang LC, Chen SC, Tsai LM, et al. Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Rheumatology (Oxford). 2020;59(6):1355-1363. DOI: 10.1093/rheumatology/kez456.Plastiras SC, Moutsopoulos HM. Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders. Arrhythm Electrophysiol Rev. 2021;10(1):17-25. DOI: 10.15420/aer.2020.43.Plastiras SC, Moutsopoulos HM. Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders. Arrhythm Electrophysiol Rev. 2021;10(1):17-25. DOI: 10.15420/aer.2020.43.Sordillo PP, Sordillo DC, Helson L. Review: The Prolonged QT Interval: Role of Pro-inflammatory Cytokines, Reactive Oxygen Species and the Ceramide and Sphingosine-1 Phosphate Pathways. In Vivo. 2015;29(6):619-36. PMID: 26546519.Sordillo PP, Sordillo DC, Helson L. Review: The Prolonged QT Interval: Role of Pro-inflammatory Cytokines, Reactive Oxygen Species and the Ceramide and Sphingosine-1 Phosphate Pathways. In Vivo. 2015;29(6):619-36. PMID: 26546519.Masoud S, Lim PB, Kitas GD, Panoulas V. Sudden cardiac death in patients with rheumatoid arthritis. World J Cardiol. 2017;9(7):562-573. DOI: 10.4330/wjc.v9.i7.562.Masoud S, Lim PB, Kitas GD, Panoulas V. Sudden cardiac death in patients with rheumatoid arthritis. World J Cardiol. 2017;9(7):562-573. DOI: 10.4330/wjc.v9.i7.562.Myasoedova E, Chandran A, Ilhan B, Major BT, Michet CJ, Matteson EL, et al. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease. Ann Rheum Dis. 2016;75(3):560-5. DOI: 10.1136/annrheumdis-2014-206411.Myasoedova E, Chandran A, Ilhan B, Major BT, Michet CJ, Matteson EL, et al. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease. Ann Rheum Dis. 2016;75(3):560-5. DOI: 10.1136/annrheumdis-2014-206411.Meissner Y, Zink A, Kekow J, Rockwitz K, Liebhaber A, Zinke S, et al. Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):183. DOI: 10.1186/s13075-016-1077-z.Meissner Y, Zink A, Kekow J, Rockwitz K, Liebhaber A, Zinke S, et al. Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):183. DOI: 10.1186/s13075-016-1077-z.Geraldino-Pardilla L, Russo C, Sokolove J, Robinson WH, Zartoshti A, Van Eyk J, et al. Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis. Rheumatology (Oxford). 2017;56(4):534-540. DOI: 10.1093/rheumatology/kew436.Geraldino-Pardilla L, Russo C, Sokolove J, Robinson WH, Zartoshti A, Van Eyk J, et al. Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis. Rheumatology (Oxford). 2017;56(4):534-540. DOI: 10.1093/rheumatology/kew436.Amigues I, Tugcu A, Russo C, Giles JT, Morgenstein R, Zartoshti A, et al. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis. Arthritis Rheumatol. 2019;71(4):496-506. DOI: 10.1002/art.40771.Amigues I, Tugcu A, Russo C, Giles JT, Morgenstein R, Zartoshti A, et al. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis. Arthritis Rheumatol. 2019;71(4):496-506. DOI: 10.1002/art.40771.Lazzerini PE, Capecchi PL, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A, et al. Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis. Front Cardiovasc Med. 2016;3:31. DOI: 10.3389/fcvm.2016.00031.Lazzerini PE, Capecchi PL, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A, et al. Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis. Front Cardiovasc Med. 2016;3:31. DOI: 10.3389/fcvm.2016.00031.Patel KHK, Jones TN, Sattler S, Mason JC, Ng FS. Proarrhythmic electrophysiological and structural remodeling in rheumatoid arthritis. Am J Physiol Heart Circ Physiol. 2020;319(5):H1008-H1020. DOI: 10.1152/ajpheart.00401.2020.Patel KHK, Jones TN, Sattler S, Mason JC, Ng FS. Proarrhythmic electrophysiological and structural remodeling in rheumatoid arthritis. Am J Physiol Heart Circ Physiol. 2020;319(5):H1008-H1020. DOI: 10.1152/ajpheart.00401.2020.

The authors declare that there are no conflicts of interest present.